Katie Quinn

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

August 15, 2024 Katie Quinn

Biosimilars Forum Calls on CMS to Support Lower-Cost Biosimilars and Increase Access for Patients

November 12, 2021 Katie Quinn

The Biosimilars Forum Congratulates Robert Califf on His Nomination for FDA Commissioner

October 26, 2021 Katie Quinn

Biosimilars Forum to Congress: Incentivize Biosimilars in Build Back Better Act

October 20, 2021 Katie Quinn

Biosimilars Forum Applauds FDA’s Approval of Second Interchangeable Biosimilar

October 13, 2021 Katie Quinn

New Report Finds Biosimilars Could Save States Billions of Dollars Annually

September 9, 2019 Katie Quinn

Biosimilars Forum’s Public Letter In Response to Anti-Biosimilars Op-Ed

August 22, 2019 Katie Quinn

New Analysis Encourages Employer Engagement to Help Realize Significant Savings Potential of Biosimilars

July 30, 2019 Katie Quinn

Forum Statement in Response to Senate Finance Committee Advancing its Drug Pricing Package

July 25, 2019 Katie Quinn

Forum Statement on Senate Finance Provision and New Amendment That Could Save Taxpayers and Seniors Billions

July 23, 2019 Katie Quinn

Senate Finance Provision Increasing ASP for Biosimilars Could Unlock Billions in Savings for Patients and Taxpayers